Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174301 · ClinicalTrials.gov registry record
Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 739
- Enrollment target
NCT03174301: Completed study, sponsored by University of Virginia.
NCT03174301 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 739 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03174301 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 739 participants
- Enrollment target
Study Summary
The objective of this common multicenter protocol is to test the hypothesis that algorithmic tools using clinical Neonatal Intensive Care Unit (NICU) cardiorespiratory monitoring data can detect ventilatory control instability and predict chronic and acute respiratory consequences of ventilatory control instability and autonomic dysregulation.
Primary Outcome
"Favorable": Either (1) an inpatient at 40 weeks post-menstrual age and not on oxygen, nor on other flow/pressure respiratory support, nor on inhaled/oral/IV respiratory medications, OR (2) discharged prior to 40 weeks post-menstrual age not on respiratory meds, oxygen, or other respiratory support. "Unfavorable": Either (1) Deceased at 40 weeks , (2) inpatient on meds/O2/support at 40 weeks post-menstrual age, or (3) previously discharged prior to 40 weeks on meds/O2/support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 739 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2021-06-04 |
What the finished NCT03174301 record still lists
NCT03174301 is an observational study that tracks outcomes without assigning an intervention. The registered 739 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03174301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03174301 about?
NCT03174301 is a clinical study titled "Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes". The objective of this common multicenter protocol is to test the hypothesis that algorithmic tools using clinical Neonatal Intensive Care Unit (NICU) cardiorespiratory monitoring data can detect ventilatory control instability and predict chronic and acute respiratory consequences of ventilatory con...
What is the current status of trial NCT03174301?
This trial is currently completed. The enrollment target is 739 participants. The study started on 2018-03-09. Estimated completion is 2021-06-04.
Who is sponsoring clinical trial NCT03174301?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03723928 · 739 participants · NA
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- NCT03963622 · 740 participants · NA
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
- NCT04074135 · 740 participants · Phase 2
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- NCT05215340 · 740 participants · Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI